68084-416-25 : NDC 2026 Code

68084-416-25 : Lamivudine And Zidovudine ( Lamivudine And Zidovudine )

Additionally :

You can get information about “68084-416-25” NDC code in 68084-416-25 in HTML format

HTML | 68084-416-25 in TXT (Plain Text) format

TXT | 68084-416-25 in PDF (Portable Document Format)

PDF | 68084-416-25 in XML format

XML formats.

NDC Code : 68084-416-25 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "68084-416-25",
    "PackageDescription": "30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-416-25)  &gt; 1 TABLET, FILM COATED in 1 BLISTER PACK (68084-416-95) ",
    "NDC11Code": "68084-0416-25",
    "ProductNDC": "68084-416",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Lamivudine And Zidovudine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Lamivudine And Zidovudine",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20140215",
    "EndMarketingDate": "20221231",
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA202418",
    "LabelerName": "American Health Packaging",
    "SubstanceName": "LAMIVUDINE; ZIDOVUDINE",
    "StrengthNumber": "150; 300",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2023-01-03",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": null,
    "StartMarketingDatePackage": "20150701",
    "EndMarketingDatePackage": "20221231",
    "SamplePackage": "N"
  }
}